Stein MD. Injected-drug use: complications and costs in the care of hospitalized
HIV-infected patients. J Acquir Immune Defic Syndr.1994;7:469-473.
Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment
of the intravenous drug user: 25 years later. Ann Intern Med.1993;119:1017-1028.
Brettle RP. Clinical features of drug use and drug use related HIV. Int J STD AIDS.1996;7:151-165.
Lange WR, White N, Robinson N. Medical complications of substance abuse. Postgrad Med.1992;92:205-208, 211-214.
Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and
other drug problems. Arch Gen Psychiatry.1988;45:1023-1031.
Kopstein A. Drug abuse related emergency room episodes in the United States. Br J Addict.1992;87:1071-1075.
Makower RM, Pennycook AG, Moulton C. Intravenous drug abusers attending an inner city accident and emergency
department. Arch Emerg Med.1992;9:32-39.
Fleishman JA, Hsia DC, Hellinger FJ. Correlates of medical service utilization among people with HIV infection. Health Serv Res.1994;29:527-548.
Fox K, Merrill JC, Chang H, Califano JA. Estimating the cost of substance abuse to the Medicaid Hospital Care
Program. Am J Public Health.1995;85:48-54.
Stein MD, O'Sullivan PS, Ellis P, Perrin H, Wartenberg A. Utilization of medical services by drug abusers in detoxification. J Subst Abuse.1993;5:187-193.
Single E, Robson L, Rehm J, Xie X. Morbidity and mortality attributable to alcohol, tobacco, and illicit
drug use in Canada. Am J Public Health.1999;89:385-390.
Hendryx MA, DeRyan J. Psychiatric hospitalization characteristics associated with insurance
types. Adm Policy Ment Health.1998;25:437-448.
Markson LE, McKee L, Mauskopf J, Houchens R, Fanning TR, Turner BJ. Patterns of Medicaid expenditures after AIDS diagnosis. Health Care Financ Rev.1994;15:43-59.
Ettner SL. The relationship between continuity of care and the health behaviors
of patients: does having a usual physician make a difference? Med Care.1999;37:547-555.
Turner BJ, McKee L, Fanning T, Markson LE. AIDS specialist versus generalist ambulatory care for advanced HIV
infection and impact on hospital use. Med Care.1994;32:902-916.
Etheridge RM, Craddock SG, Hubbard RL, Rounds-Bryant JL. The relationship of counseling and self-help participation to patient
outcomes in DATOS. Drug Alcohol Depend.1999;57:99-112.
Barnett PG. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction.1999;94:479-488.
Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health.2000;90:1100-1111.
Keyes M, Andrews R, Mason ML. A methodology for building an AIDS research file using Medicaid claims
and administrative data bases. J Acquir Immune Defic Syndr.1991;4:1015-1024.
Fanning TR, Turner BJ, Cosler LE.
et al. Quality of Medicaid data for HIV/AIDS: examination of a statewide database. AIDS Public Policy J.1995;10:39-47.
Turner BJ, McKee L, Silverman NS, Hauck WW, Fanning T, Markson LE. Prenatal care and birth outcomes of a cohort of HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol.1996;12:259-267.
Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York, NY: Springer-Verlag Inc; 1991.
Rawson RA, Shoptaw SJ, Obert JL.
et al. An intensive outpatient approach for cocaine abuse treatment. J Subst Abuse Treat.1995;12:117-127.
Sees KL, Delucchi KL, Masson C.
et al. Methadone maintenance vs 180-day psychosocially enriched detoxification
for treatment of opioid dependence: a randomized controlled trial. JAMA.2000;283:1303-1310.
D'Agostino RB. Tutorial in biostatistics propensity score methods for bias reduction
in the comparison of a treatment to a non-randomized control group. Stat Med.1998;17:2265-2281.
French MT, McGeart KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilization and the cost
of medical care. Soc Sci Med.2000;50:1703-1713.
Aszalos R, McDuff DR, Weintraub E, Montoya I, Schwartz R. Engaging hospitalized heroin-dependent patients into substance abuse
treatment. J Subst Abuse Treat.1999;17:149-158.
Batki SL, Sorensen JL, Young V. Hospital utilization by HIV+ and HIV− injection drug users before
and during methadone treatment. In: Program and abstracts of the XI International Conference on AIDS;
July 7-12, 1996; Vancouver, British Columbia. Abstract Mo.B. 1173.
Magura S, Nwakeze PC, Demsky SY. Pre- and in-treatment predictors of retention in methadone treatment
using survival analysis. Addiction.1998;93:51-60.
Chou CP, Hser YI, Anglin MD. Interaction effects of client and treatment program characteristics
on retention: an exploratory analysis using hierarchical linear models. Subst Use Misuse.1998;33:2281-2301.
Neimcryk SJ, Bedros A, Marconi KM, O'Neill JF. Consistency in maintaining contact with HIV-related service providers:
an analysis of the AIDS Cost and Services Utilization Study (ACSUS). J Community Health.1998;23:137-146.
Moos RH, Mertens JR, Brennan PL. Rates and predictors of four-year readmission among late-middle-aged
and older substance abuse patients. J Stud Alcohol.1994;55:561-570.
Samet JH, Saitz R, Larson MJ. A case for enhanced linkage of substance abusers to primary medical
care. Subst Abuse.1996;17:181-192.
Webber MP, Schoenbaum EE, Gourevitch MN.
et al. Temporal trends in the progression of human immunodeficiency virus
disease in a cohort of drug users. Epidemiology.1998;9:613-617.
Selwyn PA, Alcabes P, Hartel D.
et al. Clinical manifestations and predictors of disease progression in drug
users with human immunodeficiency virus infection. N Engl J Med.1992;327:1697-1703.
Gourevitch MN, Alcabes P, Wasserman WC, Arno PS. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis
among drug users at high risk for tuberculosis. Int J Tuberc Lung Dis.1998;2:531-540.
Newschaffer CJ, Laine C, Hauck WW, Fanning TR, Turner BJ. Clinic characteristics associated with reduced hospitalization of drug
users with AIDS. J Urban Health.1998;75:153-169.
Rawlings MK, Pasley M, Lapins D, Sinclair D. Impact of HAART on hospital utilization by HIV infected patients followed
in a Ryan White title III program. Intersci Conf Antimicrob Agents Chemother.1998;31:38.
Turner BJ, Newschaffer CJ, Zhang D, Cosler L, Hauck WW. Antiretroviral use and pharmacy-based measurement of adherence in post-partum
HIV-infected women. Med Care.2000;38:911-925.
Pettinati HM, Meyers K, Jensen JM, Kaplan F, Evans BD. Inpatient vs. outpatient treatment for substance dependence. Psychiatr Q.1993;64:173-182.